ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
Public
ST PHARM News
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

ST PHARM's Public Release

  • All
  • Media Focus
  • ST PHARM News
ST PHARM News[Inovation Center Time lapse Movie]Mar 6, 2023
ST PHARM NewsST PHARM participated in 2023 JP Morgan healthcare conferenceJan 4, 2023
ST PHARM NewsST PHARM, 2022 KCGS ESG rating 'B+'Dec 5, 2022
ST PHARM NewsST PHARM, 2022 Sustinvest ESG Rating 'AA'Nov 18, 2022
ST PHARM NewsST PHARM Participated in 10th International mRNA Health ConferenceOct 31, 2022
ST PHARM NewsST PHARM, Participated in CPHI 2022 FrankfrutOct 17, 2022
ST PHARM NewsST PHARM, Frost & Sullivan Best Practices Virtual Awards CeremonyAug 17, 2022
ST PHARM NewsST PHARM, FDA cGMP certification for oligo plant in Korea, for the first time in AsiaAug 2, 2022
ST PHARM NewsST PHARM 'STP1002' Preclinical Result EJC PublishedJul 19, 2022
ST PHARM NewsST PHARM Acquired EcoVadis Silver Grade CertificationJul 11, 2022
ST PHARM NewsST PHARM Announces HIV-1 / AIDS Treatment Drug 'STP0404' Phase 1 Clinical Trial Results 'Positive and Safe'Jul 6, 2022
ST PHARM NewsST PHARM, Awarded 2022 Asia-Pacific Oligonucleotide CDMO Campany by Frost & SullivanMay 2, 2022
ST PHARM NewsST PHARM, Participated in TIDES USA 2022 Conference As a Gold sponsorMay 2, 2022
3of4
HOMEPublicPR (Public Relations)News roomST PHARM News
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
© 2025 ST Pharm. All rights reserved.
  • Sitemap
  • Contact